BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 17935666)

  • 21. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
    Kim HJ; Min WS; Cho BS; Eom KS; Kim YJ; Min CK; Lee S; Cho SG; Jin JY; Lee JW; Kim CC
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):704-17. PubMed ID: 19450755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors and treatment of hemorrhagic cystitis in children who underwent hematopoietic stem cell transplantation.
    Cheuk DK; Lee TL; Chiang AK; Ha SY; Lau YL; Chan GC
    Transpl Int; 2007 Jan; 20(1):73-81. PubMed ID: 17181656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune-related late-onset hemorrhagic cystitis post allogeneic hematopoietic stem cell transplantation.
    Huang XJ; Liu DH; Xu LP; Zhang HY; Liu KY
    Chin Med J (Engl); 2008 Sep; 121(18):1766-9. PubMed ID: 19080354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High incidence of invasive aspergillosis associated with intestinal graft-versus-host disease following nonmyeloablative transplantation.
    Labbé AC; Su SH; Laverdière M; Pépin J; Patiño C; Cohen S; Kiss T; Lachance S; Sauvageau G; Busque L; Roy DC; Roy J
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1192-200. PubMed ID: 17889356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Full myeloablative conditioning and an unrelated HLA mismatched donor increase the risk for BK virus-positive hemorrhagic cystitis in allogeneic hematopoetic stem cell transplanted patients.
    Dalianis T; Ljungman P
    Anticancer Res; 2011 Mar; 31(3):939-44. PubMed ID: 21498717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence of Viral and fungal infections following busulfan-based reduced-intensity versus myeloablative conditioning in pediatric allogeneic stem cell transplantation recipients.
    Satwani P; Baldinger L; Freedman J; Jacobson JS; Guerra J; van de Ven C; Morris E; Garvin J; George D; Bradley MB; Bhatia M; Tallamy B; Schwartz J; Jin Z; Cairo MS
    Biol Blood Marrow Transplant; 2009 Dec; 15(12):1587-95. PubMed ID: 19896083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BK-viruria and haemorrhagic cystitis are more frequent in allogeneic haematopoietic stem cell transplant patients receiving full conditioning and unrelated-HLA-mismatched grafts.
    Giraud G; Priftakis P; Bogdanovic G; Remberger M; Dubrulle M; Hau A; Gutmark R; Mattson J; Svahn BM; Ringden O; Winiarski J; Ljungman P; Dalianis T
    Bone Marrow Transplant; 2008 Apr; 41(8):737-42. PubMed ID: 18176615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Analysis of risk factors for the development of acute graft-versus-host disease in 151 cases of allo-hematopoietic stem cell transplantation].
    Chen Y; Lu DP; Liu KY; Dong LJ; Ren HY; Huang XJ; Chen H; Liu DH; Jiang Q; Chen YH; Xu LP; Zhang YC; Lu J; Gao ZY
    Zhonghua Xue Ye Xue Za Zhi; 2005 Feb; 26(2):74-7. PubMed ID: 15921621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The role of BK polyomavirus in the development of hemorrhagic cystitis after hematopoietic stem cell transplantation].
    Xie Y; Han Y; Wu DP
    Zhonghua Nei Ke Za Zhi; 2008 Sep; 47(9):746-9. PubMed ID: 19080201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase.
    Xiao-Jun H; Lan-Ping X; Kai-Yan L; Dai-Hong L; Huan C; Wei H; Yu-Hong C; Jing-Zhi W; Yao C; Xiao-Hui Z; Hong-Xia S; Dao-Pei L
    Ann Med; 2008; 40(6):444-55. PubMed ID: 18608121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A risk score for early cytomegalovirus reactivation after allogeneic stem cell transplantation identifies low-, intermediate-, and high-risk groups: reactivation risk is increased by graft-versus-host disease only in the intermediate-risk group.
    George B; Kerridge IH; Gilroy N; Huang G; Hertzberg MS; Bradstock KF; Gottlieb DJ
    Transpl Infect Dis; 2012 Apr; 14(2):141-8. PubMed ID: 22283838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytomegalovirus viremia, viruria and disease after autologous peripheral blood stem cell transplantation: no need for surveillance.
    Bilgrami S; Aslanzadeh J; Feingold JM; Bona RD; Clive J; Dorsky D; Edwards RL; Tutschka PJ
    Bone Marrow Transplant; 1999 Jul; 24(1):69-73. PubMed ID: 10435738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Late-onset hemorrhagic cystitis after hematopoietic stem cell transplantation in children.
    Kondo M; Kojima S; Kato K; Matsuyama T
    Bone Marrow Transplant; 1998 Nov; 22(10):995-8. PubMed ID: 9849697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytomegalovirus infection in children undergoing hematopoietic stem cell transplantation in Chile.
    Paris C; Kopp K; King A; Santolaya ME; Zepeda AJ; Palma J
    Pediatr Blood Cancer; 2009 Sep; 53(3):453-8. PubMed ID: 19418548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytomegalovirus infection in children who underwent hematopoietic stem cell transplantation at a single center: a retrospective study of the risk factors.
    Yoon HS; Lee JH; Choi ES; Seo JJ; Moon HN; Kim MN; Im HJ
    Pediatr Transplant; 2009 Nov; 13(7):898-905. PubMed ID: 19032414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized trial of high dose polyvalent intravenous immunoglobulin (HDIgG) vs. Cytomegalovirus (CMV) hyperimmune IgG in allogeneic hemopoietic stem cell transplants (HSCT).
    Zikos P; Van Lint MT; Lamparelli T; Gualandi F; Occhini D; Mordini N; Berisso G; Bregante S; Bacigalupo A
    Haematologica; 1998 Feb; 83(2):132-7. PubMed ID: 9549924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemorrhagic cystitis: a retrospective single-center survey.
    Hassan Z; Remberger M; Svenberg P; Elbander M; Omazic B; Mattsson J; Conrad R; Svahn BM; Ahlgren A; Sairafi D; Aschan J; Le Blanc K; Barkholt L; Ringdén O
    Clin Transplant; 2007; 21(5):659-67. PubMed ID: 17845642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Male predominance among Japanese adult patients with late-onset hemorrhagic cystitis after hematopoietic stem cell transplantation.
    Asano Y; Kanda Y; Ogawa N; Sakata-Yanagimoto M; Nakagawa M; Kawazu M; Goyama S; Kandabashi K; Izutsu K; Imai Y; Hangaishi A; Kurokawa M; Tsujino S; Ogawa S; Aoki K; Chiba S; Motokura T; Hirai H
    Bone Marrow Transplant; 2003 Dec; 32(12):1175-9. PubMed ID: 14647272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CMV infection is a risk factor for hemorrhagic cystitis after hematopoietic stem cell transplantation.
    Zhang L; Khadka B; Wu J; Feng Y; Long B; Xiao R; Liu J
    Ann Hematol; 2023 May; 102(5):1193-1201. PubMed ID: 36752843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Allogeneic hematopoietic stem cell transplantation from HLA one-locus-mismatched related donors].
    Hyo R; Taguchi J; Kamijo A; Tanaka M; Hashimoto C; Kanamori H; Motomura S; Maruta A; Ishigatsubo Y
    Gan To Kagaku Ryoho; 2009 Nov; 36(11):1845-9. PubMed ID: 19920386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.